Immodulon Therapeutics Ltd

Immodulon is a late-stage clinical biotechnology company focused on developing an immunomodulator to enhance cancer therapy. The company aims to address the needs of patients with difficult-to-treat cancers by priming and boosting the immune response.
  • Cancer immunotherapy
  • IMM-101 immunomodulatory agent
  • Combination therapies for difficult-to-treat tumours
Size
Small
Phone
+44 (0) 20 3137 6346
Website
immodulon.com
Email
Available in Endole App
Locations
6-9 The Square, UB11 1FW
02031376346
Digital Popularity
Popularity over time
Social Media
Company Details
Immodulon Therapeutics Ltd is operated by Immodulon Therapeutics Limited and is a In Administration company incorporated on 23 April 2007 with the registered office located in London, City of London. Immodulon Therapeutics Limited was registered 18 years ago.
Status
In Administration
Size
Micro
Directors
7
Age
18 years old
Employees
4
Turnover
Unreported
Total Assets
£2.82M
Cash in Bank
£1.71M
Total Liabilities
-£1M
Richard John Davies
Director • British • Lives in Switzerland • Born in Jun 1961
Sir Simon Manwaring Robertson
Director • Lives in UK • Born in Mar 1941
Dr Joseph Oliver Mason
Director • Investor And Company Director • Irish • Lives in Ireland • Born in Jul 1965
Anthony John Bolton
Director • British • Lives in England • Born in Mar 1950
Gertjan Bartlema
Director • Biotech Executive • Swiss • Lives in Switzerland • Born in Mar 1972
Dr Selwyn Justin Ho
Director • Doctor • British • Lives in England • Born in Dec 1970
More information on Immodulon Therapeutics Limited
Teams
All
1
Owen Vaughan
Chief Regulatory Officer • Joined May 2023